1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RELMADA THERAPEUTICS INC
Relmada Therapeutics Inc
XNAS: RLMD
7.64 0.12 (1.60%)
Near 52W High of $7.94
944.1K
XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Relmada Therapeutics Inc is on 12 May 2026 for the purpose of Relmada Therapeutics Inc First Quarter Earnings Results for 2026 See details

Detailed Stock Analysis for Relmada Therapeutics Inc with Real-time Stock Report

Download Sample Report
crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in